AGEN1307
AGEN1307 is a human monoclonal antibody (mAb) targeting TIGIT. AGEN1307 has an active FcγR binding region and enhances antibody-dependent cellular cytotoxicity (ADCC) . AGEN1307 can be used in cancer research[1].
Product Specifications
Product Name Alternative
AGEN1327
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[AGEN1307]
References & Citations
[1]Rotte A, et al. Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development. Biomedicines. 2021 Sep 21;9 (9) :1277.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15100326 1 Vial
Lentiviral human PRAMEF11 shRNA (UAS) - Lentiviral human PRAMEF11 shRNA (UAS) (100)
Sign In for Pricing
View Details 
301439-AP 100 µL
P2RY2 (P2Y2, P2-Y2, P2Y Purinoceptor 2, PY 2) (AP) discontinued
Sign In for Pricing
View Details